These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 27866880)

  • 21. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
    Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study.
    Fischer M; Kao D; Mehta SR; Martin T; Dimitry J; Keshteli AH; Cook GK; Phelps E; Sipe BW; Xu H; Kelly CR
    Am J Gastroenterol; 2016 Jul; 111(7):1024-31. PubMed ID: 27185076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
    Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
    Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
    Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
    Björkqvist O; Rangel I; Serrander L; Magnusson C; Halfvarson J; Norén T; Bergman-Jungeström M
    PLoS One; 2021; 16(4):e0249861. PubMed ID: 33836037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
    Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
    Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
    Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
    J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage transfer during faecal microbiota transplantation in
    Zuo T; Wong SH; Lam K; Lui R; Cheung K; Tang W; Ching JYL; Chan PKS; Chan MCW; Wu JCY; Chan FKL; Yu J; Sung JJY; Ng SC
    Gut; 2018 Apr; 67(4):634-643. PubMed ID: 28539351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
    Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
    World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
    Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
    J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.
    Hefazi M; Patnaik MM; Hogan WJ; Litzow MR; Pardi DS; Khanna S
    Mayo Clin Proc; 2017 Nov; 92(11):1617-1624. PubMed ID: 29101931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
    Furuya-Kanamori L; Doi SA; Paterson DL; Helms SK; Yakob L; McKenzie SJ; Garborg K; Emanuelsson F; Stollman N; Kronman MP; Clark J; Huber CA; Riley TV; Clements AC
    J Clin Gastroenterol; 2017 Feb; 51(2):145-150. PubMed ID: 26974758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
    Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A
    Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.